Firm
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points
    
    
      
        
    
      
    
    
    
  Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and innovation
    
    
      
        
    
      
    
    
    
  Evarist Kameja and Hadija Juma at Bowmans explain why a new law in Tanzania marks a significant shift in IP enforcement
    
    
      
        
    
      
    
    
    
  Cohausz & Florack, together with Krieger Mes & Graf von der Groeben, has taken action against Amazon on behalf of three VIA LA licensors
    
    
    
      
        
    
      
    
    
  
        Sponsored
      
    
    
      Sponsored
- 
          
            Sponsored by Tilleke & GibbinsThe measures represent a ‘strategic leap’ for Vietnam’s intellectual property landscape, say Thuy Thi Ngoc Huynh and Yen Thi Hai Pham of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins
- 
          
            Sponsored by Hanol IP & LawMin Son of Hanol IP & Law analyses a ruling that clarifies the scope of patent infringement, territoriality limits, and research exemptions in a cross-border dispute over Pfizer’s pneumococcal vaccine
- 
          
            Sponsored by Saint Island International Patent & Law OfficesJulia Y M Hung of Saint Island International Patent & Law Offices explains the implications of a ruling confirming that assignees inherit both rights and defects, even in cases involving an unsettled distributorship dispute
- 
          
            Sponsored by Spoor & FisherDavid Cochrane of Spoor & Fisher South Africa explains the key updates under the act, which strengthens breeder protections while supporting vulnerable farmers and aligning with international norms
- 
          
            Sponsored by Maiwald Intellectual PropertyKerstin Wolff of Maiwald Intellectual Property examines the EU’s winding path towards the regulation of new genomic techniques, with a proposed patent ban remaining a key source of contention
- 
          
            Sponsored by InspicosPeter Koefoed of Inspicos examines an Enlarged Board of Appeal decision on whether the internal structure of a commercially available but undisclosed product can form part of the state of the art
 
    
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
